← All indications
Healthcare-Associated Pneumonia
Infection of the lung often accompanied by inflammation that is acquired through an interaction within a healthcare institution often through a therapeutic experience (e.g., use of catheters or ventilators).
Subtype terms (1)
More specific conditions that are subtypes of Healthcare-Associated Pneumonia in the MeSH hierarchy.
- Pneumonia, Ventilator-Associated
83 drugs (61 approved, 22 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (10)
Phase 3 trials (28)
Phase 1 trials (1)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (20)
- Peninsula Pharmaceuticals
- The Medicines Company
- Theravance
- Basilea Pharmaceutica
- AstraZeneca
- Merck
- Shionogi
- Cubist
- Polyphor Ltd.
- Changi General Hospital
- Duke University
- Mahidol University
- Nanjing Medical University
- Singapore General Hospital
- Siriraj Hospital
- University of Naples Frederico II
- National University of Singapore
- Tianjin Medical University
- Nanyang Technological University
- University of Campania Luigi Vanvitelli
Organization Involved with Phase 2 Indications (7)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (3)